Trial Profile
Combination of Atazanavir and Raltegravir as Dual Strategy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2012
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Raltegravir (Primary)
- Indications HIV infections
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms CARDS
- 20 Mar 2012 Status changed from recruiting to completed as reported by EudraCT.
- 17 Jun 2011 New trial record